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Abstract—We propose spectral domain Doppler optical
coherence tomography (SD-D-OCT) to qualitatively mea-
sure red blood cell aggregation. Variance/standard deviation
(SD) of the Doppler frequency spectrum in Doppler variance
imaging of ﬂowing blood under shearing conditions was
developed as a new aggregation index. In in vitro micro-
channel-ﬂow experiments, porcine blood at various hema-
tocrits with aggregation characteristics induced by dextran
500 or at the presence of plasma ﬁbrinogen was measured by
a SD-D-OCT system with a spectrum centered at 1310 nm.
The effects of shear rate, hematocrit, aggregation level on the
SD values were investigated. The results demonstrate that
Doppler variance imaging using the SD value was capable of
differentiating the normal and the aggregated blood with
hematocrits of 30–55% ﬂowing at a shear rate of 40–60 s
21.
The SD value was found to be nonsigniﬁcant hematocrit-
dependent. It is also a sensitive and repeatable aggregation
index for comparison between nonaggregated and aggre-
gated blood samples.
Keywords—Doppler optical coherence tomography, Doppler
variance image, Red blood cell aggregation, Velocity varia-
tion.
INTRODUCTION
The reversible aggregation of human red blood cells
(RBCs) continues to be of interest in the ﬁeld of
hemorheology because RBC aggregation is a major
determinant of the in vitro rheological properties of
blood and the in vivo ﬂow dynamics and ﬂow resistance
of blood.
2 An abnormally high level of RBC aggre-
gation has been observed in many disease states, such
as diabetes, thrombosis, myocardial infarction, vascu-
lar diseases, and hematological pathology.
9 There is
now general agreement regarding the correlations
between elevated levels of ﬁbrinogen or other large
plasma proteins and enhanced RBC aggregation and
platelet aggregation.
22,32 RBC aggregation can also be
induced by large macromolecules such as high molec-
ular weight dextrans and other polymers.
6
RBC aggregation can be assessed using diﬀerent
techniques, including erythrocyte sedimentation rate
(ESR), zeta sedimentation rate, low-shear viscometry,
image analysis in a ﬂow chamber, ultrasound back-
scattering,
10–12,39 and photometry.
14,25 Recording the
intensity of transmitted or back-scattered light under
shearing conditions has been widely used to assess
different aspects of RBC aggregation. Several com-
mercially available instruments of optical aggregome-
try in a photometric shearing system have been
developed using the principles developed by Schmid-
Scho ¨ nbein et al.
24 In optical aggregometry, the cells
should be completely disaggregated, by applying a high
shear rate (i.e., 500–600 s
21), where they are suddenly
exposed to zero-ﬂow conditions or slowed to a shear
rate of 3–5 s
21, prior to testing. Light scattering sig-
nals, with respect to time, provide information about
the cell aggregation characteristics. Even though these
methods deﬁne meaningful parameters representing
RBC aggregation, these measurements are quite dif-
ferent from the actual ﬂow environment.
37 The con-
ventional aggregation parameters in terms of an
arbitrary unit ‘‘M’’ and ‘‘M1’’ with Myrenne aggre-
gometer and the laser-assisted optical rotational cell
analyzer (LORCA) may not directly relate to the
in vivo hemorheological characteristics.
18
Therefore, creating a new principle and method to
measureRBCaggregationmimickingactualinvivoﬂow
is of great interest. In our recent study, we found that
RBC aggregation of ﬂowing blood within a micro-
channel caused changes in the variance of optical
Doppler frequency spectrum using spectral domain
Doppleropticalcoherencetomography(SD-D-OCT),
33
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3210and this requires further interpretation of the proposed
index, i.e., the standard deviation (SD) of Doppler fre-
quency spectrum as an aggregation parameter as well as
the measurement principles.
Since the proposed SD of Doppler frequency spec-
trum as an aggregation parameter may be dependent
on shear rate, hematocrit, aggregation level, and geo-
metrical conditions, the present study investigates the
eﬀects of these conditions on the SD value of the
normal and aggregated blood. In addition, this study
evaluates the instrument precision and sensitivity. Our
purpose is to validate a SD of the velocity power
spectrum as a new aggregation index for qualitative
measurement of RBC aggregation.
THEORY
OCT or Doppler OCT is able to achieve high
imaging speed, high velocity sensitivity, and high spa-
tial resolution simultaneously.
8,15 It has demonstrated
considerable potential as a method for static and dy-
namic imaging of various kinds of tissue and blood.
The refractive index mismatching between RBC cyto-
plasm and blood plasma is the major source of light
scattering in blood.
17,26,28 The scattering properties of
blood are also dependent on RBC volume, shape, and
orientation, aggregation and disaggregation capability
and hematocrit (HCT). The OCT depth-reﬂectivity
proﬁle has been used to study blood optical clearing
that reduces blood scattering by biocompatible agent-
induced refractive index matching between RBCs and
plasma in order to enhance the capability of light
penetration depth, aggregation, sedimentation, and
HCT by our and other groups.
7,16,17,29,34–36 In our
previous work, we demonstrated that the slope of the
OCT depth-reﬂectivity proﬁle decreased with the level
of RBC aggregation.
35,36 This is so because RBC
aggregation leads to a decrease in scattering of
RBCs.
21 Unfortunately, the relationship between the
slope and the aggregation of RBCs could not be di-
rectly used because the slope is also HCT-dependent.
40
We have demonstrated Doppler variance tomogra-
phy using the variance of the Doppler frequency
spectrum to more eﬃciently map the ﬂows in
highly scattering biological tissues by Doppler OCT
(D-OCT).
31,40 In addition to the local velocity informa-
tion, phase-resolved D-OCT systems give the variance of
the Doppler frequency spectrum,
31,40 which is given by
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where N is the number of A-lines used for averaging; T
is the time interval between two exposures, and f(z)i sa
complex signal from an inverse Fourier transform of
the interference pattern. The corresponding Doppler
shift can be estimated by comparing the phasors of f(z)
between two complex signals during two exposures at a
same location. The phase change is recorded by the
product of fjT(z)a n df*(j+1)T(z), where * denotes the
conjugate operation. The value of r
2 depends on the
ﬂow velocity distribution. Variations of ﬂow velocity
broaden the Doppler frequency spectrum and result in
a larger r
2. Thus, the Doppler variance obtained by
phase-resolved D-OCT systems can be an indicator of
ﬂow variations.
Individual particles within concentrated suspensions
exhibit signiﬁcant random movements when the sus-
pension is subjected to shear ﬂow. These movements
are dependent on the local shear rate of the suspension
and on particle size.
4 Previous studies have shown
variation in the instantaneous velocity of individual
RBCs and the effect of aggregation on the dispersion
of RBCs ﬂowing in venules.
5,27 RBC aggregation in the
ﬂow stream decreases the variability in instantaneous
cellular velocity.
5 This effect is most likely the result of
an increased particle size. The magnitude of particle
movements is decreased when the particle diameter
increases.
13,23 Therefore, decreased variance/SD in the
Doppler frequency spectrum with RBC aggregation is
expected.
MATERIALS AND METHODS
A schematic of the spectral-domain D-OCT system
is shown in Fig. 1. A super-luminescent diode (SLD)
with a spectrum centered at 1310 nm, and a full width
at half maximum bandwidth of 95 nm and a total
delivered power of 8 mW was used. Back-reﬂected
light from the reference and sample arms was guided
into a spectrometer and dispersed over a 1 9 1024
InGaAs detector array at 7.7 kHz (corresponding to
FIGURE 1. Schematic of a ﬁber-based spectral-domain OCT
system used in the experiments (FL, focusing lens; DG, dif-
fraction grating; CM, collimator; LSC, line-scan camera).
Red Blood Cell Aggregation Measurement with SD-D-OCT 32111/T). The total wavelength range spreading on the
detector array was 130 nm, corresponding to a spectral
resolution of 0.13 nm and an imaging depth of 3.6 mm
in air. The resulting axial resolution was about 8 lm
and the lateral resolution of the system was about
13.8 lm.
1,36
The interference signal was inversely Fourier
transformed after reducing the DC component. In the
phase-resolved D-OCT, the phase change of the
interference fringe between sequential A-line scans was
used to calculate the Doppler frequency shift.
40 The
SD of phase shift between two consecutive exposures
(=rT) was calculated from the cross correlation using
Eq. (1).
31
Various HCT levels from 30% to 55% were
obtained by mixing extracted RBCs with porcine
plasma using ethylenediaminetetraacetic acid (EDTA)
as an anticoagulant (Animal Technologies, Inc., Tyler,
TX). Diﬀerent suspensions of normal RBCs, artiﬁ-
cially aggregated with dextran, were prepared. RBCs
were resuspended in plasma with dextran 500 (Dx500,
average molecular mass 500 kDa; Sigma-Aldrich Co.,
St. Louis, MO, USA). A plasma dextran concentration
of 0.5–2% [in weight/volume (w/v)] was used to induce
the RBC aggregation. In another set of experiments,
the RBCs were resuspended in PBS for the control
samples and in 400 mg/dL ﬁbrinogen (F4129, Sigma-
Aldrich Co., St. Louis, MO, USA) PBS solution for
the aggregating samples at a HCT of 40%. For in vivo
situation, ﬁbrinogen or other large plasma proteins
enhance RBC aggregation rather than dextran. The
experiments are to further demonstrate that the vari-
ance can reﬂect the erythrocyte aggregation mimicking
the in vivo situation. All OCT measurements were
performed just after RBC suspensions were prepared
and pumped through a round glass capillary tube with
a 300-lm inner diameter (VitroCom Inc., Mountain
Lakes, NJ) at a Doppler angle of 5. The two ends of
the glass tube were connected with two around 50 cm-
long plastic tubes to develop a lamina ﬂow. A pro-
grammable syringe pump (Harvard Apparatus, Holl-
iston, MA) was used to make the blood ﬂow with an
approximately constant speed at a rate of 1.1, 2.3, and
3.4 mm/s, corresponding to a pseudo shear rate of 20,
40, and 60 s
21. The shear rate simulates the real values
within major human retinal venular vessels. OCT
‘‘M-scans’’ (a single A-line repeatedly acquired in time
without transverse scanning) were performed. A total
of 512 OCT A-lines were acquired in a M-mode scan
with the probe beam targeting at the center of the tube.
It takes about 66 ms for the acquisition. Averaging is
used to improve the measurement sensitivity. All ﬁnal
results of SD values for both normal and aggregated
blood were means of ﬁve separate measurements on
aliquots of a sample. Each measurement consisted of
triplicate data acquired from the same aliquot. A
paired t test statistical analysis was applied for the
differences in SD between the control group (without
dextran) and the treated group (with dextran). For all
tests, a level of 0.05 was chosen as a signiﬁcant level.
Instrument precision for SD parameter was assessed
by calculating the coeﬃcient of variation (CV) of 12
measurements on aliquots of normal porcine blood
samples with ﬁxed HCT at 40% at the ﬂow rate of
15 lL/min within the 300 lm microchannel; each
measurement consisted of triplicate determinations
followed by introducing a new aliquot. To determine
the sensitivity of the aggregation parameter, two
groups of blood samples, i.e., the normal blood group
and the blood with 2% Dx500, with ﬁxed HCT at 40%
were measured. The ‘‘standardized diﬀerence’’ between
these two groups for SD parameter was calculated by
dividing the diﬀerence between the two groups by the
mean of the two standard deviations for that param-
eter. Note that a higher standardized diﬀerence for a
parameter indicates that the parameter has a higher
power to detect a diﬀerence in aggregation.
RESULTS AND DISCUSSION
Standard Deviation Measurement for RBC Aggregation
Characterization
Figure 2 shows the OCT structural images (Figs. 2a
and 2b) and the Doppler variance images that give the
variation of the blood velocity distribution for the
blood without dextran (Fig. 2c) and the aggregated
blood with 0.5% Dx500 (Fig. 2d) at HCT of 40%
ﬂowing through a 300-lm glass tube at a shear rate of
60 s
21. The different OCT signals between the control
blood (Fig. 2a) and the aggregated blood (Fig. 2b) are
visualized in the blood with 0.5% Dx500. The presence
of different velocity variations between the control and
the aggregated within the glass tube was observed
(Figs. 2(c) and 2d). Note that, although the measured
proﬁle of the Doppler velocity ﬁts closely to a parabolic
shape, the SD data are not perfectly symmetrical about
the r = 0 axis. The results might be because Doppler
velocity is a direct measurement of the phase difference
between adjacent A-lines, while the (complex) SD
measurement is a function of both the phase and
amplitude of adjacent A-lines (according to Eq. 1). The
SD will hold a parabolic distribution if the amplitude is
uniform across all cross-sectional A-lines. However, the
amplitude is normally not a uniform distribution given
the existence of speckle noise and velocity-related mo-
tion artifacts (sensitivity reduction) of the ﬂow.
The quantitative values of the SD along the depth
calculated according to (1) for the control and the
XU et al. 3212treated blood were determined and are plotted in
Fig. 3 for HCT of 40% (Fig. 3a) and HCT of 55%
(Fig. 3b) at a shear rate of 60 s
21. For the nonaggre-
gated blood at HCTs of 40% or 55%, the upper lines
of the SD proﬁles in Figs. 3a and 3b show that the
velocity ﬂuctuations vary with radial position in the
glass tube. A higher SD is found near the center of the
tube where the shear rate is minimal for the ﬂow. The
decrease in the SD in the center of the tube could be
the result of a decrease in the variability in instanta-
neous cellular velocity due to changes in the size of
scatterers associated with RBC aggregation. When
aggregates migrate to the center of the tube, particle
size will be greater in the center of the tube than near
the tube wall.
4
The centerline SD values were calculated for each of
the RBCs ﬂowing at a shear rate of 60 s
21 and are
shown in Fig. 4. The mean values of 74.6 ± 2.8 for the
control group at a HCT of 40% is signiﬁcantly
(p<0.01) higher than the values for the aggregated
blood induced by dextran from 0.5% to 2%. The
addition of dextran decreases the SD by around 40%,
indicating the velocity variation in the aggregated
blood is reduced. This ﬁnding is consistent with the
in vivo work
5 that the magnitude of the velocity vari-
ations in dextran-treated blood is less than that in the
nonaggregating blood. It is most likely that RBCs
residing in aggregates could be both shielded from
interactions with surrounding cells and also hindered
in their movements or the magnitude of particle
movements is decreased when the particle diameter
increases.
It is known that dextran-induced aggregation is
higher at higher concentrations up to an optimum
FIGURE 2. Structural OCT images (top) and Doppler variance images (bottom) of the blood at HCT 5 40%. (a, c) Normal. (b, d) The
blood with 0.5% dextran 500.
FIGURE 3. Standard deviation vs. depth proﬁles for normal and dextran-treated blood at HCT: (a) 40% and (b) 55%.
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20 We noted that there is no signiﬁcant
difference the SD values between the samples with
dextran at concentrations of 0.5–2%. Because dextran
500 used in our experiment, which has a very high
molecular weight, is a strong aggregation inducer
producing large aggregates after the concentration
over 0.5%,
5,19 it seems that the variance cannot dis-
tinguish the size difference between the samples with
dextran at concentrations of 0.5–2% after the aggre-
gates exceeding a certain size, i.e., the SD value rapidly
drops down to around 45. Further improvement of
the signal-to-noise ratio of the SD-D-OCT system may
be helpful to address the issue. Nevertheless, dextran is
only used to demonstrate the method and dextran 500
at 0.6% is widely used to induce RBC aggregation in
the range for healthy humans.
5,19 Studies on mimick-
ing the in vivo situation with ﬁbrinogen at the mea-
sured concentrations and blood samples from patients
that the actual aggregation is assessed are under way to
develop a quantitative method rather than the current
qualitative method.
Figure 5 shows the Doppler variance images that
give the variation of the blood velocity distribution for
the control (Fig. 5a) and the aggregating blood with
ﬁbrinogen (Fig. 5b) at a HCT of 40% ﬂowing through
a 300-lm glass tube at a shear rate of 40 s
21. The
quantitative values of SD along the depth calculated
for the control and the aggregating blood are plotted in
Fig. 5c. The presence of different velocity variations
between the two groups was evident. The centerline SD
for each of the RBCs ﬂowing at shear rates of 40 and
60 s
21 is shown in Fig. 6. Fibrinogen at 400 mg/dL
results in a signiﬁcant decrease in the SD by 26.7%
(p<0.01) at 40 s
21 and 39.8% (p<0.01) at 60 s
21,
respectively.
Eﬀect of Shear Rate on SD Measurements
Figure 7 shows the centerline SD of 40% blood
under three shear rates of 20, 40, and 60 s
21 for the
normal (nonaggregating) and 2% Dx500-treated
(aggregating) blood. As expected, the SD value
increases with increasing shear rate for both groups.
When dextran is added to the ﬂowing blood, RBC
aggregation causes a signiﬁcant decrease in the SD
values at 40 and 60 s
21.
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FIGURE 4. Difference in mean centerline SD for the blood
(HCT 40%) at various concentrations of dextran. Values for
dextran-treated blood are signiﬁcantly (p<0.01) smaller than
those for normal blood.
FIGURE 5. Doppler variance images of the normal (a) and the aggregating blood with ﬁbrinogen (b) at HCT of 40%, (c) quantitative
values of SD along the depth for the normal and the aggregating blood.
XU et al. 3214Hematocrit Dependence
Figure 8 shows the centerline SD of control blood
with HCTs from 30% to 55% at shear rates of 40 and
60 s
21. The SD value tends to decrease with increasing
HCT, but that is not signiﬁcantly affected at the both
shear rates. In other words, the SD value is nonsig-
niﬁcant dependence on hematocrits in the range of 30–
55%. The relationship between the SD value and HCT
is quite unlike that between scattering and HCT. We
and other groups have reported very large changes in
attenuation with HCT.
16,36
Instrument Precision and Sensitivity
The mean, standard deviation, and the coeﬃcient of
variation (CV) for 12 repeated measurements on ali-
quots of the same control blood sample are 74.6%,
2.8%, and 3.8%, indicating the SD measured by the
SD-D-OCT system is highly repeatable. The percent-
age diﬀerence and standardized diﬀerence between the
two groups (n = 12 for each group) of the control and
the aggregating blood with 2% Dx500 are 60.4% and
8.16. The standardized difference is much larger than
that of commercial available optical aggregometers
(Table 1).
3 The large percentage difference and stan-
dardized difference between the two groups implies the
SD value is highly sensitive to aggregation difference.
The data presented in this work point to the possi-
bility of optical Doppler variance determination of the
RBC aggregation. In all our experiments, RBC
aggregation induced by dextran or at the presence of
ﬁbrinogen caused a practically 30–40% decrease in the
SD of Doppler frequency spectrum. The normal blood
has a SD value larger than 70 and the aggregated
blood has a SD value smaller than 50 at a pseudo shear
rate of 60 s
21. The shear rates between 40–60 s
21
mimicking the venular vessels where RBC aggregation
often exists were found to be optional operating ﬂow
velocities for sensitivity, especially higher signal-to-
noise ratio at 60 s
21.
One may speculate why the dimension of the round
microchannel with an inner diameter of 300 lm was
used. Typical RBC aggregometers have similar
dimensions for their present channel gap. For instance,
the LORCA has a 300 lm gap in concentric annulus.
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FIGURE 6. Centerline SD values of the normal blood and the
blood with ﬁbrinogen at shear rates of 40 and 60 s
21.
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FIGURE 7. Centerline SD values of the blood (HCT 40%)
under three shear rates of 20, 40, and 60 s
21 for the normal
blood and 2% Dx500-treated blood. The value for 20 s
21 with
2% dextran is not shown in the ﬁgure because it drops down
to noise level and so meaningless.
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FIGURE 8. Centerline SD values of the control blood at HCTs
from 30% to 55% at shear rates of 40 and 60 s
21.
TABLE 1. Comparison of instrument precision and sensitiv-
ity between Doppler variance method and light transmission
method.
4
Parameter Mean
Standard
deviation
CV
(%)
Percentage
difference
Standardized
difference
Doppler
variance
74.6 2.8 3.8 60.4 8.16
M index
a 24.9 1.18 4.73 75.5 2.55
aM index: integrating the area under the syllectogram curve (light
transmission curves) after a sudden stop of shearing.
Red Blood Cell Aggregation Measurement with SD-D-OCT 3215Myrenne aggregometer has an approximately 70 lm
gap in a cone-plate geometry, which may limit the
formation of normal 3D aggregates.
We have found a new qualitative measure of red
blood cell aggregation, directly measured through a
SD of the velocity power spectrum. The new qualita-
tive index function can provide information matching
the in vivo microvascular blood ﬂow with shear rates of
40–60 s
21 and is of nonsigniﬁcant hematocrit depen-
dence. However, for practical use, a quantitative model
relating the SD to the aggregate size is needed. A wide
range of aggregation schemes are possible for RBCs
(e.g., diffusion limited aggregation or rouleaux pat-
terns) and understanding their impact on velocity
ﬂuctuations is very challenging. Furthermore, as
known, the Doppler frequency shift depends on the
Doppler angle between the probe and ﬂow directions
and would vary during in vivo measurements. How-
ever, it was demonstrated that variance imaging is less
sensitive to the Doppler angle during in vitro and
in vivo measurements in our previous results.
30,38
Nevertheless, we currently aim to develop an optical-
microﬂuidic rheometry with a ﬁxed Doppler angle for
in vitro routine medical test. Although the variance of
Doppler frequency spectrum is less sensitive to the
Doppler angle, the studies on the possible effects on
in vivo measurements are under way. Except for the
possible effects of the Doppler angle, the phase insta-
bility caused by bulk-motion artifacts and optical
heterogeneity are also the limitations for in vivo use. A
technique to be established using the new index to
quantitate RBC aggregation either for in vitro or
in vivo measurements requires further studies.
CONCLUSIONS
We proposed SD-D-OCT technique to qualitatively
measure RBC aggregation with high sensitivity and
reproducibility. The SDof Doppler frequencyspectrum
of RBCs in ﬂowing blood was validated as a new RBC
aggregation index, which was independent of blood
hematocrit. Clear evidence of correlation between the
SD value of Doppler frequency spectrum and RBC
aggregation induced by dextran and ﬁbrinogen which is
similar to in vivo blood ﬂow was demonstrated.
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